Your browser doesn't support javascript.
loading
Safety and Immunogenicity of ChAd63/MVA Pfs25-IMX313 in a Phase I First-in-Human Trial.
de Graaf, Hans; Payne, Ruth O; Taylor, Iona; Miura, Kazutoyo; Long, Carol A; Elias, Sean C; Zaric, Marija; Minassian, Angela M; Silk, Sarah E; Li, Lee; Poulton, Ian D; Baker, Megan; Draper, Simon J; Gbesemete, Diane; Brendish, Nathan J; Martins, Filipa; Marini, Arianna; Mekhaiel, David; Edwards, Nick J; Roberts, Rachel; Vekemans, Johan; Moyle, Sarah; Faust, Saul N; Berrie, Eleanor; Lawrie, Alison M; Hill, Fergal; Hill, Adrian V S; Biswas, Sumi.
Afiliação
  • de Graaf H; NIHR Clinical Research Facility, University Hospital Southampton NHS Foundation Trust and Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
  • Payne RO; The Jenner Institute, University of Oxford, Oxford, United Kingdom.
  • Taylor I; The Jenner Institute, University of Oxford, Oxford, United Kingdom.
  • Miura K; Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, United States.
  • Long CA; Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, United States.
  • Elias SC; The Jenner Institute, University of Oxford, Oxford, United Kingdom.
  • Zaric M; The Jenner Institute, University of Oxford, Oxford, United Kingdom.
  • Minassian AM; The Jenner Institute, University of Oxford, Oxford, United Kingdom.
  • Silk SE; The Jenner Institute, University of Oxford, Oxford, United Kingdom.
  • Li L; The Jenner Institute, University of Oxford, Oxford, United Kingdom.
  • Poulton ID; The Jenner Institute, University of Oxford, Oxford, United Kingdom.
  • Baker M; The Jenner Institute, University of Oxford, Oxford, United Kingdom.
  • Draper SJ; The Jenner Institute, University of Oxford, Oxford, United Kingdom.
  • Gbesemete D; NIHR Clinical Research Facility, University Hospital Southampton NHS Foundation Trust and Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
  • Brendish NJ; NIHR Clinical Research Facility, University Hospital Southampton NHS Foundation Trust and Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
  • Martins F; NIHR Clinical Research Facility, University Hospital Southampton NHS Foundation Trust and Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
  • Marini A; The Jenner Institute, University of Oxford, Oxford, United Kingdom.
  • Mekhaiel D; The Jenner Institute, University of Oxford, Oxford, United Kingdom.
  • Edwards NJ; The Jenner Institute, University of Oxford, Oxford, United Kingdom.
  • Roberts R; The Jenner Institute, University of Oxford, Oxford, United Kingdom.
  • Vekemans J; GSK Vaccines, Wavre, Belgium.
  • Moyle S; Clinical Biomanufacturing Facility, University of Oxford, Oxford, United Kingdom.
  • Faust SN; NIHR Clinical Research Facility, University Hospital Southampton NHS Foundation Trust and Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
  • Berrie E; Clinical Biomanufacturing Facility, University of Oxford, Oxford, United Kingdom.
  • Lawrie AM; The Jenner Institute, University of Oxford, Oxford, United Kingdom.
  • Hill F; OSIVAX​​, Lyon, France.
  • Hill AVS; The Jenner Institute, University of Oxford, Oxford, United Kingdom.
  • Biswas S; The Jenner Institute, University of Oxford, Oxford, United Kingdom.
Front Immunol ; 12: 694759, 2021.
Article em En | MEDLINE | ID: mdl-34335606
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Plasmodium falciparum / Vacinas Sintéticas / Malária Falciparum / Vacinas Antimaláricas / Imunogenicidade da Vacina Tipo de estudo: Clinical_trials Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Front Immunol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Plasmodium falciparum / Vacinas Sintéticas / Malária Falciparum / Vacinas Antimaláricas / Imunogenicidade da Vacina Tipo de estudo: Clinical_trials Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Front Immunol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido